New Delhi: An Indian pharma company now finds itself in the eye of a storm as Uzbekistan claimed that 18 children have died in the country after consuming medicines manufactured by Noida-based Marion Biotech.
As per reports on a local Uzbek news website, the government said that 21 kids were hospitalised with acute respiratory diseases – a side-effect of consuming the cough syrup Dok-One Max, which Marion Biotech allegedly manufactures. 18 of these children have since died.
Uzbek health ministry claimed that the primary laboratory studies have shown the presence of ethylene glycol in the syrup. It is the same chemical that is a common contaminant in pharma products made without adequate safeguards.
India on Tuesday launched an inquiry into a Noida-based drugs manufacturer after the deaths of 18 children in Uzbekistan were linked to the firm. A criminal probe has also been initiated by the State Security Service of the Central Asian nation.
Bhubaneswar: Extensive crop loss and distress caused by unseasonal rains reportedly claimed the lives of…
Bhubaneswar: The Odisha capital is all set to host Pravasi Bharatiya Divas (PBD) Convention, the…
Bhubaneswar: Putting all speculation to rest, Sambalpur SP Mukesh Kumar Bhamoo on Monday confirmed that…
Cuttack: Almost a year after being granted divorce, actor Anubhav Mohanty has challenged his ex-wife…
New York: About 63 million Americans are under weather alerts. The country is in grip…
Bengaluru: Amid the outbreak of Human Metapneumovirus (HMPV) cases in China over the past few…
This website uses cookies.